Seroatlas · Human Serome Atlas

GCK

Hexokinase-4

Also known as: HK4, HXK4_HUMAN, MODY2

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P35557
Gene
GCK
Ensembl
ENSG00000106633
Chromosome
7
Canonical length
465 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
Subcellular location
Cytosol

OverviewNCBI Gene

This gene encodes a member of the hexokinase family of proteins. Hexokinases phosphorylate glucose to produce glucose-6-phosphate, the first step in most glucose metabolism pathways. In contrast to other forms of hexokinase, this enzyme is not inhibited by its product glucose-6-phosphate but remains active while glucose is abundant. The use of multiple promoters and alternative splicing of this gene result in distinct protein isoforms that exhibit tissue-specific expression in the pancreas and liver. In the pancreas, this enzyme plays a role in glucose-stimulated insulin secretion, while in the liver, this enzyme is important in glucose uptake and conversion to glycogen. Mutations in this gene that alter enzyme activity have been associated with multiple types of diabetes and hyperinsulinemic hypoglycemia. [provided by RefSeq, Aug 2017]

Canonical amino-acid sequenceUniProt

465 residues, UniProt reviewed canonical sequence.

>P35557|GCK
     1  MLDDRARMEA AKKEKVEQIL AEFQLQEEDL KKVMRRMQKE MDRGLRLETH EEASVKMLPT
    61  YVRSTPEGSE VGDFLSLDLG GTNFRVMLVK VGEGEEGQWS VKTKHQMYSI PEDAMTGTAE
   121  MLFDYISECI SDFLDKHQMK HKKLPLGFTF SFPVRHEDID KGILLNWTKG FKASGAEGNN
   181  VVGLLRDAIK RRGDFEMDVV AMVNDTVATM ISCYYEDHQC EVGMIVGTGC NACYMEEMQN
   241  VELVEGDEGR MCVNTEWGAF GDSGELDEFL LEYDRLVDES SANPGQQLYE KLIGGKYMGE
   301  LVRLVLLRLV DENLLFHGEA SEQLRTRGAF ETRFVSQVES DTGDRKQIYN ILSTLGLRPS
   361  TTDCDIVRRA CESVSTRAAH MCSAGLAGVI NRMRESRSED VMRITVGVDG SVYKLHPSFK
   421  ERFHASVRRL TPSCEITFIE SEEGSGRGAA LVSAVACKKA CMLGQ

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against GCK can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.22
Highest tissue expression
20 nTPM

Expression across tissuesHPA

Tissue

  • pituitary gland: 20 nTPM
  • liver: 17 nTPM
  • hypothalamus: 12 nTPM
  • heart muscle: 8.5 nTPM
  • cerebellum: 5.8 nTPM
  • amygdala: 5.6 nTPM

Single-cell type

  • corticotrophs: 75 nCPM
  • somatotrophs: 61 nCPM
  • thyrotrophs: 58 nCPM
  • pancreatic islet cells: 56 nCPM
  • gonadotrophs: 47 nCPM
  • lactotrophs: 32 nCPM

Immune cell

  • memory B-cell: 2.3 nTPM
  • naive CD4 T-cell: 1.9 nTPM
  • neutrophil: 0.8 nTPM
  • memory CD4 T-cell: 0.7 nTPM
  • MAIT T-cell: 0.3 nTPM
  • naive CD8 T-cell: 0.3 nTPM

Brain region

  • hypothalamus: 9.7 nTPM
  • thalamus: 7.7 nTPM
  • midbrain: 6.6 nTPM
  • pons: 5 nTPM
  • amygdala: 4.9 nTPM
  • medulla oblongata: 4.8 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about GCK.

Disease | AllUniProt

Conditions GCK is implicated in, by any mechanism.

Disease | GeneticClinVar

680 pathogenic / likely-pathogenic of 1,358 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Disease | ImmuneIEDB

Conditions an epitope on GCK was assayed in.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.44
gnomAD pLI
0.63
gnomAD missense Z
3.07
DepMap mean gene effect
0.01
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of GCK in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads GCK as an antibody target. Whether an autoantibody or antibody against GCK could matter depends on whether native GCK is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

GCK is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label GCK as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/GCK. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...